- Home
- MCRB vs SPEG Comparison
MCRB vs SPEG Comparison
Compare MCRB & SPEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- SPEG
- Stock Information
- Founded
- MCRB 2010
- SPEG 2024
- Country
- MCRB United States
- SPEG United States
- Employees
- MCRB N/A
- SPEG N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- SPEG
- Sector
- MCRB Health Care
- SPEG
- Exchange
- MCRB Nasdaq
- SPEG Nasdaq
- Market Cap
- MCRB 144.6M
- SPEG 153.2M
- IPO Year
- MCRB 2015
- SPEG 2025
- Fundamental
- Price
- MCRB $17.75
- SPEG $10.03
- Analyst Decision
- MCRB Hold
- SPEG
- Analyst Count
- MCRB 4
- SPEG 0
- Target Price
- MCRB $14.33
- SPEG N/A
- AVG Volume (30 Days)
- MCRB 101.5K
- SPEG 38.0K
- Earning Date
- MCRB 11-12-2025
- SPEG 01-01-0001
- Dividend Yield
- MCRB N/A
- SPEG N/A
- EPS Growth
- MCRB N/A
- SPEG N/A
- EPS
- MCRB 10.22
- SPEG N/A
- Revenue
- MCRB N/A
- SPEG N/A
- Revenue This Year
- MCRB N/A
- SPEG N/A
- Revenue Next Year
- MCRB N/A
- SPEG N/A
- P/E Ratio
- MCRB $1.74
- SPEG N/A
- Revenue Growth
- MCRB N/A
- SPEG N/A
- 52 Week Low
- MCRB $6.53
- SPEG $9.95
- 52 Week High
- MCRB $24.67
- SPEG $10.04
- Technical
- Relative Strength Index (RSI)
- MCRB 42.40
- SPEG N/A
- Support Level
- MCRB $17.63
- SPEG N/A
- Resistance Level
- MCRB $19.30
- SPEG N/A
- Average True Range (ATR)
- MCRB 1.12
- SPEG 0.00
- MACD
- MCRB -0.29
- SPEG 0.00
- Stochastic Oscillator
- MCRB 5.42
- SPEG 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About SPEG Silver Pegasus Acquisition Corp Class A Ordinary Shares
Silver Pegasus Acquisition Corp is a blank check company.